Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Machine Learning to Predict Tamoxifen Nonadherence Among US Commercially Insured Patients With Metastatic Breast CancerJCO Clin Cancer Inform 2021 Aug 01;5(1)814-825, G Yerrapragada, A Siadimas, A Babaeian, V Sharma, TJ O'Neill
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.